secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2025-07-29T23:59:59+00:00
Accession:  0001764013-25-000121
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant finalizes CEO Eric Venker's employment agreement with $672K salary, equity awards
--------------------------------------------------------------------------------

- Annual base salary $672,000; target annual bonus 72.25% of base salary.
- Option Awards: 1,300,000 stock options and options valued at $2,250,000 (189,900 shares), four-year vest.
- CVAR Award: 1,475,000 capped appreciation rights with performance and $16.76 stock price hurdle.
- Two-year holding period on vested shares from Unit Option Award and 87.25% of CVAR-settled shares.
- Severance: 12 months salary + target bonus + COBRA if terminated without cause or for good reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/0001764013-25-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/imvt-20250728.htm
  HTML page:      https://secwatch.observer/filing/0001764013-25-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer